Clinical and demographic factors affecting trough levels of isavuconazole in critically ill patients with or without COVID‐19Ralph Bertram, Rainer Höhl, Hans‐Theodor Naumann et al.|Mycoses|2023Cited by 19
Front & Back MatterI. Pavlík, Feng-Li Hui, Huang SiLiang et al.|Journal of Molecular Microbiology and Biotechnology|2012Cited by 0